Beijing Scitop Bio-Tech Co.Ltd(300858)
Work report of the board of directors in 2021
In 2021, the board of directors of Beijing Scitop Bio-Tech Co.Ltd(300858) (hereinafter referred to as “the company”) strictly followed the requirements of the company law, securities law, Shenzhen Stock Exchange GEM Listing Rules, Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 2 – standardized operation of companies listed on GEM, the articles of Association and the rules of procedure of the board of directors and other relevant provisions, in order to effectively safeguard the interests of the company and shareholders, Earnestly implement the resolutions of the general meeting of shareholders, diligently carry out various governance work, standardize operation and make scientific decisions, and promote the sustainable and healthy development of the company. The main work report of the board of directors in 2021 is as follows: I. overall operation of the company in 2021
In 2021, the company realized an operating revenue of 3646175 million yuan, an increase of 7.51% over the same period of last year; The net profit attributable to the shareholders of the parent company was 1095394 million yuan, an increase of 13.42% over the same period last year. 2、 Corporate governance in 2021
During the reporting period, the board of directors of the company performed its duties in strict accordance with the requirements of the company law, the securities law and relevant laws and regulations, standardized decision-making procedures and made scientific decisions; Actively improve the company’s internal control system, improve the company’s internal control and supervision system, and ensure the company’s compliant operation and efficient operation. 3、 Meetings of the board of directors and the general meeting of shareholders
During the reporting period, the board of directors of the company held 7 Board meetings. The details of the meetings are as follows:
Time: meeting name: deliberation of proposals
1. Proposal on the 2021 restricted stock incentive plan (Draft) and its summary of Beijing Ketuo Hengtong Biotechnology Co., Ltd;
The second session of the board of directors 2. Proposal on formulating the management measures for the implementation of the 2021 restricted stock incentive plan of Beijing Ketuo Hengtong Biotechnology Co., Ltd. at the seventh meeting on February 4, 2021;
3. Proposal on requesting the general meeting of shareholders to authorize the board of directors to handle matters related to the restricted stock incentive plan in 2021;
Time: meeting name: deliberation of proposals
4. Proposal on convening the first extraordinary general meeting of shareholders in 2021.
1. Proposal on Exempting the notice time limit of the eighth meeting of the second board of directors on March 10, 2021;
The 8th meeting 2. Proposal on granting restricted shares to incentive objects for the first time.
1. Proposal on 2020 general manager’s work report;
2. Proposal on the work report of the board of directors in 2020;
3. Proposal on 2020 financial final accounts report;
4. Proposal on 2020 annual report and its summary;
5. Proposal on self-evaluation report of internal control in 2020;
6. Proposal on 2020 profit distribution plan;
7. Proposal on reappointment of audit institutions in 2021;
8. Proposal on the special report on the deposit and use of raised funds in 2020;
9. Proposal of the second board of directors on the remuneration plan of directors in 2021;
The 9th meeting on April 21, 202110. Proposal on 2021 annual salary plan for senior managers;
11. Proposal on changes of accounting policies;
12. Proposal on using idle self owned funds for cash management;
13. Proposal on the prediction of daily connected transactions in 2021;
14. Proposal on the first quarter report of 2021; 15. Proposal on by election of independent directors;
16. Proposal on foreign investment and establishment of wholly-owned subsidiaries;
17. Proposal on signing the investment contract for comprehensive R & D pilot production base project with the Management Committee of Helingeer new area, Inner Mongolia;
18. Proposal on changing some investment projects with raised funds and investing in the establishment of wholly-owned subsidiaries and providing loans to implement projects with raised funds;
19. Proposal on suspending the 2020 annual general meeting of shareholders.
Time: meeting name: deliberation of proposals
1. Proposal on Amending relevant systems of the company; 1.1 proposal on Amending the working system of independent directors;
1.2 proposal on Amending the rules of procedure of the audit committee of the board of directors;
1.3 proposal on Amending the rules of procedure of the nomination committee of the board of directors;
1.4 proposal on Amending the rules of procedure of the strategy committee of the board of directors;
1.5 proposal on Amending the rules of procedure of the remuneration and assessment committee of the board of directors;
1.6 proposal on Amending the administrative measures for information disclosure;
1.7 proposal of the second board of directors on May 13, 2021 on Amending the measures for the administration of investor relations;
1.8 proposal on Revising the internal reporting system of major information at the 10th meeting;
1.9 proposal on Amending the company’s shares held by directors, supervisors and senior managers and their change management system;
1.10 amendments to the regulations on the prevention of controlling shareholders and other related matters
